NASDAQ
Denali Therapeutics Inc. (DNLI) has a current ratio of 9.16x as of Monday, May 25, 2026. This represents a 29.68% increase compared to its 12-month average of 7.06x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.